Schröder, L.; Rupp, A.B.A.; Gihr, K.M.E.; Kobilay, M.; Domroese, C.M.; Mallmann, M.R.; Holdenrieder, S.
Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies. Cancers 2023, 15, 5081.
https://doi.org/10.3390/cancers15205081
AMA Style
Schröder L, Rupp ABA, Gihr KME, Kobilay M, Domroese CM, Mallmann MR, Holdenrieder S.
Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies. Cancers. 2023; 15(20):5081.
https://doi.org/10.3390/cancers15205081
Chicago/Turabian Style
Schröder, Lars, Alexander B. A. Rupp, Kathrin M. E. Gihr, Makbule Kobilay, Christian M. Domroese, Michael R. Mallmann, and Stefan Holdenrieder.
2023. "Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies" Cancers 15, no. 20: 5081.
https://doi.org/10.3390/cancers15205081
APA Style
Schröder, L., Rupp, A. B. A., Gihr, K. M. E., Kobilay, M., Domroese, C. M., Mallmann, M. R., & Holdenrieder, S.
(2023). Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies. Cancers, 15(20), 5081.
https://doi.org/10.3390/cancers15205081